(Q42990258)

12 November 2017

title

Is there an optimal time to measure quantitative HCV RNA to predict non-response following interferon treatment for chronic HCV infection? (English)

1 reference

12 November 2017

McHutchison J

1

1 reference

12 November 2017

Blatt L

2

1 reference

12 November 2017

Sedghi-Vaziri A

3

1 reference

12 November 2017

Russell J

4

1 reference

12 November 2017

Schmid P

5

1 reference

12 November 2017

Conrad A

6

1 reference

12 November 2017

publication date

1 September 1998

1 reference

12 November 2017

published in

Journal of Hepatology

1 reference

12 November 2017

volume

29

1 reference

12 November 2017

issue

3

1 reference

12 November 2017

page(s)

362-368

1 reference

The treatment of chronic viral hepatitis

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980052-4

7 January 2021

Interferon for non-A, non-B chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980052-4

7 January 2021

Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980052-4

7 January 2021

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980052-4

7 January 2021

Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980052-4

7 January 2021

Prediction of response to interferon treatment of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980052-4

7 January 2021

Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980052-4

7 January 2021

Loss of serum HCV RNA at week 4 of interferon‐α therapy is associated with more favorable long‐term response in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980052-4

7 January 2021

Hepatitis C virus genotypes 1 and 2 respond to interferon-alpha with different virologic kinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980052-4

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980052-4

7 January 2021

Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980052-4

7 January 2021

Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980052-4

7 January 2021

Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980052-4

7 January 2021

Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980052-4

7 January 2021

A histopathological study of the effects of 6-month versus 12-month interferon α-2b therapy in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980052-4

7 January 2021

Long-term decrease in serum N-terminal propeptide of type III procollagen in patients with chronic hepatitis C treated with interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980052-4

7 January 2021

Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980052-4

7 January 2021

10.1016/S0168-8278(98)80052-4

Identifiers

DOI

1 reference

12 November 2017

1 reference